![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![Minakem Generic APIs](https://www.pharmacompass.com/image/flap/minakem-header-desktop-w27gif-57924.gif)
![Minakem Generic APIs](https://www.pharmacompass.com/image/flap/minakem-header-mobile-w27gif-62411.gif)
Applications:
Ingredient(s): Croscarmellose Sodium
Dosage Form: Tablet
Category: Direct Compression, Disintegrants & Superdisintegrants, Granulation
Technical Specifications: NA
Applications:
Ingredient(s): Croscarmellose Sodium
Dosage Form: Tablet
Category: Disintegrants & Superdisintegrants, Granulation
Technical Specifications: Not Available
Applications:
Ingredient(s): Anhydrous Lactose
Dosage Form: Tablet
Category: Direct Compression, Granulation
Technical Specifications: Milled; Also Available as Microlex® LCA 120.m, Microlex® LCA 200.m
Applications:
Solubility and bioavailability enhancement, ideal for hot melt extrusion (HME)
Ingredient(s): polyethylene glycol, Polyvinyl Acetate
Dosage Form: Solution, Tablet, Topical Film, Transdermal Patch
Category: Controlled & Modified Release, Granulation, Solubilizers
Technical Specifications: Not Available